Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...

Pancreatic cancer remains one of the deadliest diagnoses in oncology. Only about 13% of patients survive five years, and for ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...

Researchers at The University of Texas MD Anderson Cancer Center have identified an epigenetic target for replication stress, ...

A homegrown Northwestern drug is giving Chicago-area families something they almost never get with metastatic pancreatic ...

Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a ...

Researchers headed by a team at NYU Langone Health have discovered that a feature of pancreatic cancer cells’ surroundings determines whether they grow fast or become resistant to chemotherapy. The ...

Researchers at Oregon Health & Science University have discovered that pancreatic cancer cells reshape their environment by ...